1
/
of
0
FDA Drug Approval, N016807, THYROLAR-5
FDA Drug Approval, N016807, THYROLAR-5
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
NDA: 016807
Company: ALLERGAN
Drug Name: THYROLAR-5
Active Ingredients: LIOTRIX (T4;T3)
Strength: 0.25MG;0.0625MG
Dosage Form/Route: TABLET;ORAL
Action Date: 11/21/1969
Marketing Status: Discontinued
Submission Classification: Type 5 - New Formulation or New Manufacturer
Company: ALLERGAN
Drug Name: THYROLAR-5
Active Ingredients: LIOTRIX (T4;T3)
Strength: 0.25MG;0.0625MG
Dosage Form/Route: TABLET;ORAL
Action Date: 11/21/1969
Marketing Status: Discontinued
Submission Classification: Type 5 - New Formulation or New Manufacturer
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details